18.89
                                            Schlusskurs vom Vortag:
              $19.09
            Offen:
              $19
            24-Stunden-Volumen:
                675.75K
            Relative Volume:
              1.06
            Marktkapitalisierung:
                $1.42B
            Einnahmen:
              $122.87M
            Nettoeinkommen (Verlust:
              $-73.68M
            KGV:
              -19.27
            EPS:
                -0.9803
            Netto-Cashflow:
                $-39.27M
            1W Leistung:
              +2.27%
            1M Leistung:
              +11.51%
            6M Leistung:
                +45.76%
            1J Leistung:
              +42.24%
            Zymeworks Inc. Stock (ZYME) Company Profile
Firmenname
                  
                      Zymeworks Inc.
                    
                Sektor
                  Branche
                  Telefon
                  
                      604-678-1388
                    
                Adresse
                  
                      1385 West 8th Avenue, Suite 540, Vancouver, BC
                    
                Vergleichen Sie ZYME mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ZYME
                            
                             
                        Zymeworks Inc. 
                           | 
                    18.89 | 1.45B | 122.87M | -73.68M | -39.27M | -0.9803 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-10-24 | Fortgesetzt | Wells Fargo | Equal Weight | 
| 2025-10-14 | Hochstufung | H.C. Wainwright | Neutral → Buy | 
| 2025-10-10 | Eingeleitet | B. Riley Securities | Buy | 
| 2025-05-20 | Eingeleitet | TD Cowen | Buy | 
| 2024-12-16 | Hochstufung | JP Morgan | Neutral → Overweight | 
| 2024-11-07 | Hochstufung | Leerink Partners | Market Perform → Outperform | 
| 2024-11-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight | 
| 2023-03-21 | Fortgesetzt | Wells Fargo | Overweight | 
| 2023-01-04 | Bestätigt | H.C. Wainwright | Neutral | 
| 2022-12-20 | Hochstufung | Jefferies | Hold → Buy | 
| 2022-11-01 | Herabstufung | H.C. Wainwright | Buy → Neutral | 
| 2022-10-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform | 
| 2022-10-04 | Fortgesetzt | Wells Fargo | Overweight | 
| 2022-05-05 | Hochstufung | Guggenheim | Neutral → Buy | 
| 2022-03-15 | Eingeleitet | Evercore ISI | Outperform | 
| 2021-12-10 | Hochstufung | SVB Leerink | Mkt Perform → Outperform | 
| 2021-11-17 | Fortgesetzt | Guggenheim | Neutral | 
| 2021-10-07 | Eingeleitet | Jefferies | Hold | 
| 2021-03-31 | Eingeleitet | Credit Suisse | Outperform | 
| 2021-02-25 | Herabstufung | SVB Leerink | Outperform → Mkt Perform | 
| 2021-02-08 | Fortgesetzt | H.C. Wainwright | Buy | 
| 2021-01-25 | Herabstufung | Citigroup | Buy → Neutral | 
| 2020-09-29 | Fortgesetzt | JP Morgan | Neutral | 
| 2020-08-06 | Eingeleitet | SVB Leerink | Outperform | 
| 2020-01-10 | Eingeleitet | Wolfe Research | Outperform | 
| 2019-12-09 | Eingeleitet | JP Morgan | Neutral | 
| 2019-11-25 | Eingeleitet | H.C. Wainwright | Buy | 
| 2019-11-20 | Eingeleitet | Guggenheim | Buy | 
| 2019-09-30 | Hochstufung | Raymond James | Outperform → Strong Buy | 
| 2019-08-30 | Eingeleitet | Stifel | Buy | 
| 2019-07-18 | Eingeleitet | Deutsche Bank | Buy | 
| 2018-05-11 | Hochstufung | Barclays | Underweight → Equal Weight | 
| 2018-03-19 | Eingeleitet | Raymond James | Outperform | 
                    Alle ansehen
                    
                  
                Zymeworks Inc. Aktie (ZYME) Neueste Nachrichten
How to use Fibonacci retracement on Zymeworks Inc.Portfolio Risk Summary & Reliable Price Action Trade Plans - newser.com
Is Zymeworks Inc. stock bottoming outJuly 2025 News Drivers & Smart Money Movement Alerts - newser.com
Applying Elliott Wave Theory to Zymeworks Inc.July 2025 Catalysts & Weekly High Momentum Picks - newser.com
Published on: 2025-11-03 08:56:43 - newser.com
How Zymeworks Inc. stock compares to market leadersWeekly Volume Report & Capital Protection Trading Alerts - newser.com
Is Zymeworks Inc. (ZA8) stock cheap vs fundamentals2025 EndofYear Setup & Verified Chart Pattern Signals - newser.com
What technical patterns form on Zymeworks Inc. (ZA8) stock chartsBond Market & AI Driven Stock Movement Reports - newser.com
Is Zymeworks Inc. stock a contrarian buyEarnings Risk Report & Verified Trade Idea Suggestions - newser.com
Will Zymeworks Inc. stock sustain high P E ratiosMarket Risk Report & Real-Time Market Trend Scan - newser.com
How moving averages guide Zymeworks Inc. trading2025 Price Targets & Community Consensus Picks - newser.com
Can Zymeworks Inc. stock rebound after recent weaknessRisk Management & Free High Accuracy Swing Entry Alerts - newser.com
Will Zymeworks Inc. stock attract ESG investors2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
Why Zymeworks Inc. (ZA8) stock could outperform next yearWeekly Market Summary & Safe Entry Zone Identification - newser.com
Will Zymeworks Inc. stock gain from strong economyQuarterly Portfolio Report & Smart Swing Trading Techniques - newser.com
Is Zymeworks Inc. forming a bottoming baseMarket Volume Summary & Weekly High Conviction Ideas - newser.com
What sentiment indicators say about Zymeworks Inc. stockBond Market & Capital Protection Trading Alerts - newser.com
How Zymeworks Inc. (ZA8) stock performs in volatility spikesJuly 2025 Volume & Comprehensive Market Scan Reports - newser.com
Custom strategy builders for tracking Zymeworks Inc.Trade Risk Assessment & Verified Swing Trading Watchlists - newser.com
How Zymeworks Inc. (ZA8) stock stacks up against competitors2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Why Zymeworks Inc. stock is in analyst buy zoneWatch List & Verified Momentum Stock Alerts - newser.com
Is Zymeworks Inc. (ZA8) stock nearing a technical breakout2025 Price Targets & Smart Allocation Stock Reports - newser.com
Zymeworks, Inc. Hits New 52-Week High at $19.98 - Markets Mojo
Zymeworks Inc. (NASDAQ:ZYME) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Zymeworks (NASDAQ:ZYME) Reaches New 52-Week HighStill a Buy? - MarketBeat
Zymeworks Inc. (ZYME) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Zymeworks stock hits 52-week high at $19.87 By Investing.com - Investing.com Australia
Is now a turning point for Zymeworks Inc.Index Update & Fast Entry High Yield Stock Tips - newser.com
Zymeworks stock hits 52-week high at $19.87 - Investing.com
Zymeworks Inc. (ZYME) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Finanzdaten der Zymeworks Inc.-Aktie (ZYME)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):